Adverse effects outnumber benefits, although there is still a subgroup of patients with HVPG < 10 mm of Hg at basal level which must be defined.
Los efectos adversos de los fármacos superan el beneficio y queda por definir el subgrupo de pacientes con GPVH < de 10 mmHg a nivel basal.